Whiting Samuel (CIK 0001870373)

Latest company ownership

Role: Chief Medical Officer
Shares held
9,573
Last filed at
Jul 3, 2024
Confidence Score
50.0
2025Q4
Confidence Score History
2022Q1 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Jul 2, 2024 Jul 3, 2024 Tempest Therapeutics, Inc. Chief Medical Officer Buy 90.0 +4,672 95.33% $10K
Jan 6, 2022 Jan 10, 2022 Tempest Therapeutics, Inc. Chief Medical Officer Buy 90.0 +1,700 845.77% $8.2K